Alexandria Real Estate Equities
ARE
#2310
Rank
HK$64.07 B
Marketcap
HK$372.34
Share price
-0.61%
Change (1 day)
-42.59%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -HK$4.52 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are HK$2.76 Billion. In 2025 the company made an earning of -HK$7.77 Billion a decrease over its 2024 earnings that were of HK$5.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$4.52 Billion-41.83%
2025 -HK$7.77 Billion-242.13%
2024 HK$5.46 B96.11%
2023 HK$2.78 B-53.56%
2022 HK$6.00 B-3.96%
2021 HK$6.24 B-20.26%
2020 HK$7.83 B72.88%
2019 HK$4.53 B3.11%
2018 HK$4.39 B73.54%
2017 HK$2.53 B464.88%
2016 HK$0.44 B-77.32%
2015 HK$1.97 B36.31%
2014 HK$1.45 B-10.81%
2013 HK$1.62 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$54.18 B-1,282.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$263.56 B-5,849.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$80.70 B-1,860.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$15.34 Billion 234.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.10 B-298.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$93.43 B-2,138.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$8.82 B-292.46%๐Ÿ‡บ๐Ÿ‡ธ USA